Standard Biotools LAB
NASDAQ LAB
$0.73 +0.02 (+2.69%)
As of: Sep 30, 2026 · 10:20 AM EDT

Standard Biotools (LAB) EBITDA Margin (2010 - 2026)

Updated

Standard Biotools (LAB) posted EBITDA Margin of -119.95% for Q2 2026, down 20.22 percentage points from -99.73% a year earlier and down 67.52 percentage points from the prior quarter.

Analysis

Standard Biotools (LAB) EBITDA Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Standard Biotools was -106.35%, down 5.65 percentage points year-over-year; for FY2025, it came in at -116.34%, up 5.22 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -90.92 percentage points (FY2020 to FY2025).
  • In prior years, Standard Biotools' EBITDA Margin was -121.55% in FY2024 (-63.80 pp), -57.76% in FY2023 (+45.54 pp), -103.30% in FY2022 (-63.56 pp) and -39.74% in FY2021 (-14.32 pp).
  • Quarterly EBITDA Margin has run from a low of -200.71% in Q2 2022 to a high of -35.48% in Q4 2021 over five years.
  • On a year-over-year basis, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -7.91 percentage points.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2023, with a gain of 150.75 percentage points; the weakest was Q2 2022, with a drop of 170.88 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -52.44% (Q1 2026), -98.14% (Q4 2025) and -160.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 21.86%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 41.08%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.55%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 28.17%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 31.93%
10 Standard Biotools 286.25 Mn -1.03 Bn 10.54 Mn -119.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -119.95%
Mar 31, 2026 -52.44%
Dec 31, 2025 -98.14%
Sep 30, 2025 -160.68%
Jun 30, 2025 -99.73%
Mar 31, 2025 -112.74%
Dec 31, 2024 -89.31%
Sep 30, 2024 -103.42%
Jun 30, 2024 -117.40%
Mar 31, 2024 -120.75%
Dec 31, 2023 -62.01%
Sep 30, 2023 -67.75%
Jun 30, 2023 -49.96%
Mar 31, 2023 -51.48%
Dec 31, 2022 -75.10%
Sep 30, 2022 -110.06%
Jun 30, 2022 -200.71%
Mar 31, 2022 -88.79%
Dec 31, 2021 -35.48%
Sep 30, 2021 -47.90%
API Access

Standard Biotools EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LAB&period=max&api_key=YOUR_API_KEY